TrialSchizophrenia bulletin2026

Effects of Empagliflozin and Lifestyle Intervention on Improving Body Weight and Other Metabolic Parameters in Atypical Antipsychotics-treated Patients with Schizophrenia Spectrum Disorders-A Double-blind Randomized Placebo-controlled Trial.

Sin-Ying Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.